Latest news
Arcus Biosciences (RCUS) Stock Gets Fair Value Bump After Casdatifan Optimism - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 05:10:00 GMTRCUS Dec 2026 40.000 call (RCUS261218C00040000) interactive stock chart - Yahoo Finance UKYahoo Finance UK · Fri, 07 Aug 2026 21:23:09 GMTArcus Biosciences (NYSE: RCUS) gets 24.7% ownership from Gilead - stocktitan.netstocktitan.net · Fri, 07 Aug 2026 20:31:22 GMTRCUS Dec 2026 40.000 call (RCUS261218C00040000) interactive stock chart – Yahoo Finance - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 19:55:36 GMTArcus Biosciences Inc (RCUS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKeyTradingKey · Fri, 07 Aug 2026 09:26:20 GMTArcus Biosciences (RCUS) Stock Can Casdatifan Carry Mounting Losses - simplywall.stsimplywall.st · Thu, 06 Aug 2026 23:02:37 GMTArcus Biosciences (NYSE:RCUS) Price Target Raised to $26.00 - MarketBeatMarketBeat · Thu, 06 Aug 2026 18:32:26 GMTRCUS Maintained by Wedbush -- Price Target Raised to $43.00 - GuruFocusGuruFocus · Thu, 06 Aug 2026 18:27:16 GMT